Answers are grounded in this paper and cite their sources.
Background: Robotic-assisted surgery has become an increasingly prominent component of modern healthcare, with the da Vinci Surgical System representing one of the most widely adopted platforms. Despite its technological advantages, including enhanced instrument articulation, three-dimensional visualization, and improved surgical ergonomics, questions remain regarding its comparative clinical effectiveness, economic accessibility, and broader implications for healthcare systems. Aim: This review critically examines the available evidence concerning the clinical outcomes and economic implications of da Vinci-assisted procedures compared with conventional laparoscopic and open surgery. Materials and Methods: Particular attention is given to operative time, postoperative complications, hospital stay, surgical conversion rates, and healthcare expenditure. The review also considers the influence of institutional resources, surgical expertise, and technological accessibility on the implementation of robotic-assisted procedures. Results: Recent comparative studies indicate that robotic surgery may offer advantages in selected surgical settings; however, these benefits are not consistently demonstrated across all procedures and patient populations. Furthermore, substantial financial requirements and methodological limitations in existing economic evaluations complicate conclusions regarding cost-effectiveness. Conclusions: The findings highlight the importance of procedure-specific evidence and balanced healthcare investment decisions. Robotic-assisted surgery should therefore be evaluated not solely as a technological innovation but as a healthcare intervention whose clinical value, affordability, and accessibility must be assessed together.
No takes yet. Share an insight, caveat, or question.
Shchebetun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: